Cargando…
Precision medicine advancements in glioblastoma: A systematic review
BACKGROUND: Glioblastoma multiforme, commonly known as GBM or glioblastoma is a grade IV astrocytoma. Brain tumors are difficult to treat and lead to poor prognosis and survival in patients. Gliomas are categorized into four different grades among which GBM is the worst grade primary brain tumor wit...
Autores principales: | Iyer, Karan, Saini, Shubham, Bhadra, Suman, Kulavi, Sohini, Bandyopadhyay, Jaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627207/ https://www.ncbi.nlm.nih.gov/pubmed/37937301 http://dx.doi.org/10.37796/2211-8039.1403 |
Ejemplares similares
-
Systems Medicine for Precise Targeting of Glioblastoma
por: Zeng, Jie, et al.
Publicado: (2023) -
Extracellular vesicles: The key for precision medicine in glioblastoma
por: Del Bene, Massimiliano, et al.
Publicado: (2021) -
The potential of advanced MR techniques for precision radiotherapy of glioblastoma
por: Tang, Patrick L. Y., et al.
Publicado: (2022) -
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020) -
Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023)